Trial Profile
A Multicenter, Randomized, Double Blind, Parallel Design Trial to Evaluate the Blood Pressure Lowering Efficacy Comparing Moderate Versus Aggressive Treatment Regimen of Valsartan + Amlodipine in Patients Uncontrolled on ARB Monotherapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms EXTRA
- Sponsors Novartis
- 21 Jun 2010 Results have been presented at the 20th European Meeting on Hypertension.
- 18 Jun 2010 Results were presented at the 20th European Meeting on Hypertension.
- 01 May 2010 Results were presented at the 25th Annual Scientific Meeting of the American Society of Hypertension.